Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	P. Cahn, J. Sierra Madero, J. Arribas, A. Antinori, R. Ortiz, A. Clarke, C. Hung, J. Rockstroh, P. Girard, J. Sievers, C. Man, R. Urbaityte, M. Underwood, A. Tenorio, K. Pappa, B. Wynne, M. Gartland, M. Aboud, J. van Wyk, K. Smith, Y. El-Bahy
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2020-02-01
Cyfres:	Journal of Infection and Public Health
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S1876034120301192
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg